Edward C. Stites

1.6k total citations
36 papers, 772 citations indexed

About

Edward C. Stites is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Edward C. Stites has authored 36 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 15 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Edward C. Stites's work include Protein Kinase Regulation and GTPase Signaling (11 papers), Melanoma and MAPK Pathways (8 papers) and Cancer Genomics and Diagnostics (7 papers). Edward C. Stites is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (11 papers), Melanoma and MAPK Pathways (8 papers) and Cancer Genomics and Diagnostics (7 papers). Edward C. Stites collaborates with scholars based in United States, Spain and Australia. Edward C. Stites's co-authors include Kodi S. Ravichandran, Andréy S. Shaw, Paul C. Trampont, Meraj Aziz, Hiruy S. Meharena, Jiancheng Hu, Philip A. Stork, Susan S. Taylor, Alexandr P. Kornev and Elizabeth Germino and has published in prestigious journals such as Science, Cell and Nature Communications.

In The Last Decade

Edward C. Stites

33 papers receiving 758 citations

Peers

Countries citing papers authored by Edward C. Stites

Since Specialization

Citations

This map shows the geographic impact of Edward C. Stites's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward C. Stites with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward C. Stites more than expected).

Fields of papers citing papers by Edward C. Stites

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward C. Stites. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward C. Stites. The network helps show where Edward C. Stites may publish in the future.

Co-authorship network of co-authors of Edward C. Stites

This figure shows the co-authorship network connecting the top 25 collaborators of Edward C. Stites. A scholar is included among the top collaborators of Edward C. Stites based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward C. Stites. Edward C. Stites is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cost-effectiveness of Lynch Syndrome Screening in Colorectal Cancer: Universal Germline vs Sequential Screening 2025 ·Clinical Gastroenterology and Hepatology ·Satoko Ito, Rosa M. Xicola, (unknown), (unknown), (unknown), Peter Gershkovich, Edward C. Stites, Joanna Gibson, Harlan M. Krumholz, Xavier Llor, George Goshua	0
2	Cancer research is not correlated with driver gene mutation burdens 2024 ·Med ·Gaurav Mendiratta, (unknown), (unknown), Satoko Ito, Eugene Ke, George Goshua, Edward C. Stites	0
3	Decreasing alloimmunization‐specific mortality in sickle cell disease in the United States: Cost‐effectiveness of a shared transfusion resource 2024 ·American Journal of Hematology ·Satoko Ito, Ankur Pandya, Ronald G. Hauser, Lakshmanan Krishnamurti, Edward C. Stites, Christopher A. Tormey, Harlan M. Krumholz, Jeanne E. Hendrickson, George Goshua	2
4	Systems modeling of oncogenic G-protein and GPCR signaling reveals unexpected differences in downstream pathway activation 2024 ·npj Systems Biology and Applications ·(unknown), (unknown), Nadia Arang, Kathryn Lande, (unknown), (unknown), Mathieu F. Bakhoum, J. Silvio Gutkind, Edward C. Stites	2
5	Theoretical analysis reveals a role for RAF conformational autoinhibition in paradoxical activation 2023 ·eLife ·Gaurav Mendiratta, Edward C. Stites	1
6	How often is each gene mutated within the cancer patient population? 2022 ·Molecular & Cellular Oncology ·Gaurav Mendiratta, (unknown), Edward C. Stites	3
7	Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP 2022 ·npj Precision Oncology ·(unknown), (unknown), (unknown), John F. Langenheim, (unknown), Edward C. Stites	9
8	Cancer gene mutation frequencies for the U.S. population 2021 ·Nature Communications ·Gaurav Mendiratta, Eugene Ke, Meraj Aziz, (unknown), (unknown), Edward C. Stites	114
9	Identification of RAS mutant biomarkers for EGFR inhibitor sensitivity using a systems biochemical approach 2021 ·Cell Reports ·(unknown), Edward C. Stites	14
10	Mathematical Modeling to Study KRAS Mutant-Specific Responses to Pathway Inhibition 2021 ·Methods in molecular biology ·Edward C. Stites	3
11	Discernment between candidate mechanisms for KRAS G13D colorectal cancer sensitivity to EGFR inhibitors 2020 ·Cell Communication and Signaling ·(unknown), (unknown), Kent L. Rossman, Edward C. Stites	14
12	The Interpretation of SARS-CoV-2 Diagnostic Tests 2020 ·Med ·Edward C. Stites, Craig B. Wilen	23
13	A systems mechanism for KRAS mutant allele–specific responses to targeted therapy 2019 ·Science Signaling ·(unknown), Jolene K. Diedrich, (unknown), (unknown), (unknown), (unknown), James J. Moresco, Andréy S. Shaw, Edward C. Stites	45
14	Modeling cell line-specific recruitment of signaling proteins to the insulin-like growth factor 1 receptor 2019 ·PLoS Computational Biology ·Keesha E. Erickson, Oleksii S. Rukhlenko, (unknown), (unknown), Yen Ting Lin, (unknown), Edward C. Stites, Marian Anghel, Richard G. Posner, Dipak Barua, Boris Ν. Kholodenko, William S. Hlavacek	7
15	Use of Mechanistic Models to Integrate and Analyze Multiple Proteomic Datasets 2015 ·Biophysical Journal ·Edward C. Stites, Meraj Aziz, Matthew S. Creamer, Daniel D. Von Hoff, Richard G. Posner, William S. Hlavacek	18
16	Allosteric Activation of Functionally Asymmetric RAF Kinase Dimers 2013 ·Cell ·Jiancheng Hu, Edward C. Stites, Haiyang Yu, Elizabeth Germino, Hiruy S. Meharena, Philip A. Stork, Alexandr P. Kornev, Susan S. Taylor, Andréy S. Shaw	215
17	Chemical kinetic mechanistic models to investigate cancer biology and impact cancer medicine 2013 ·Physical Biology ·Edward C. Stites	3
18	Specification, annotation, visualization and simulation of a large rule-based model for ERBB receptor signaling 2012 ·BMC Systems Biology ·Matthew S. Creamer, Edward C. Stites, Meraj Aziz, James A. Cahill, Chin Wee Tan, Michael E. Berens, Haiyong Han, Kimberly J. Bussey, Daniel D. Von Hoff, William S. Hlavacek, Richard G. Posner	27
19	Mathematical Investigation of How Oncogenic Ras Mutants Promote Ras Signaling 2012 ·Methods in molecular biology ·Edward C. Stites, Kodi S. Ravichandran	8
20	Mechanistic modeling to investigate signaling by oncogenic Ras mutants 2011 ·WIREs Systems Biology and Medicine ·Edward C. Stites, Kodi S. Ravichandran	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact